BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8827192)

  • 1. The management of treatment resistance in depressed patients with substance use disorders.
    Nunes EV; Deliyannides D; Donovan S; McGrath PJ
    Psychiatr Clin North Am; 1996 Jun; 19(2):311-27. PubMed ID: 8827192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis.
    Nunes EV; Levin FR
    JAMA; 2004 Apr; 291(15):1887-96. PubMed ID: 15100209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of treatment-resistant depression in the medically ill.
    Franco-Bronson K
    Psychiatr Clin North Am; 1996 Jun; 19(2):329-50. PubMed ID: 8827193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.
    Torrens M; Fonseca F; Mateu G; Farré M
    Drug Alcohol Depend; 2005 Apr; 78(1):1-22. PubMed ID: 15769553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder.
    Gruber AJ; Hudson JI; Pope HG
    Psychiatr Clin North Am; 1996 Jun; 19(2):351-69. PubMed ID: 8827194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment-resistant depression is treatable].
    Vinberg M; Levinsen MF; Kessing LV
    Ugeskr Laeger; 2011 Feb; 173(9):651-4. PubMed ID: 21362393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe depression: is there a best approach?
    Sonawalla SB; Fava M
    CNS Drugs; 2001; 15(10):765-76. PubMed ID: 11602003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does substance use compromise depression treatment in persons with HIV? Findings from a randomized controlled trial.
    Grelotti DJ; Hammer GP; Dilley JW; Karasic DH; Sorensen JL; Bangsberg DR; Tsai AC
    AIDS Care; 2017 Mar; 29(3):273-279. PubMed ID: 27590273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated treatment of comorbid depression and substance use disorders.
    Charney DA; Paraherakis AM; Gill KJ
    J Clin Psychiatry; 2001 Sep; 62(9):672-7. PubMed ID: 11681761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of depression in the elderly.
    Williams GO
    Prim Care; 1989 Jun; 16(2):451-74. PubMed ID: 2664841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of antidepressants in the treatment of adolescents and young adults with depression and substance use disorders: a systematic review and meta-analysis.
    Zhou X; Qin B; Del Giovane C; Pan J; Gentile S; Liu Y; Lan X; Yu J; Xie P
    Addiction; 2015 Jan; 110(1):38-48. PubMed ID: 25098732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cocaine dependence and depression.
    Rounsaville BJ
    Biol Psychiatry; 2004 Nov; 56(10):803-9. PubMed ID: 15556126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment-resistant depression: no panacea, many uncertainties. Adverse effects are a major factor in treatment choice.
    Prescrire Int; 2011 May; 20(116):128-33. PubMed ID: 21648180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysthymia, depression, and a treatment dilemma in a patient with polysubstance abuse.
    Silk A; Shaffer H
    Harv Rev Psychiatry; 1996; 3(5):279-84. PubMed ID: 9384957
    [No Abstract]   [Full Text] [Related]  

  • 15. Quality of Outpatient Depression Treatment in Patients With Comorbid Substance Use Disorder.
    Coughlin LN; Pfeiffer P; Ganoczy D; Lin LA
    Am J Psychiatry; 2021 May; 178(5):414-423. PubMed ID: 33115247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment-resistant bipolar depression.
    Sachs GS
    Psychiatr Clin North Am; 1996 Jun; 19(2):215-36. PubMed ID: 8827187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary on Zhou et al. (2015): Treating psychiatric comorbidity in adolescents--an important problem.
    Nunes EV
    Addiction; 2015 Jan; 110(1):49-50. PubMed ID: 25515829
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of Antidepressants in Patients with Co-occurring Depression and Substance Use Disorders.
    Carey TL
    Handb Exp Pharmacol; 2019; 250():359-370. PubMed ID: 30244298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.